$MVST
Microvast Holdings, Inc. Stock $mvst

$mvst Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000176068924000016 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$83.68M	$81.35M
YoY Change	11.64%	73.19%
Cost Of Revenue	$56.48M	$64.13M
YoY Change	-11.04%	52.26%
Gross Profit	$27.20M	$17.23M
YoY Change	137.28%	254.57%
Gross Profit Margin	32.5%	21.17%
Selling, General & Admin	$28.54M	$29.39M
YoY Change	-3.12%	15.81%
% of Gross Profit	104.93%	170.6%
Research & Development	$10.11M	$11.49M
YoY Change	6.31%	5.81%
% of Gross Profit	37.16%	66.72%
Depreciation & Amortization	$7.708M	$7.591M
YoY Change	51.17%	48.93%
% of Gross Profit	28.34%	44.07%
Operating Expenses	$103.6M	$40.88M
YoY Change	165.77%	12.81%
Operating Profit	-$75.63M	-$23.12M
YoY Change	181.49%	-26.14%
Interest Expense	-$1.848M	$1.732M
YoY Change	-479.47%	277.34%
% of Operating Profit
Other Income/Expense, Net	$601.0K	-$136.0K
YoY Change	-347.33%	-117.24%
Pretax Income	-$78.44M	-$24.83M
YoY Change	200.79%	-16.05%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$78.44M	-$24.83M
YoY Change	200.67%	-16.08%
Net Earnings / Revenue	-93.74%	-30.52%
Basic Earnings Per Share	-$0.25	-$0.08
Diluted Earnings Per Share	-$0.25	-$0.08
COMMON SHARES
Basic Shares Outstanding	317.2M shares	317.2M shares
Diluted Shares Outstanding	315.5M shares	315.4M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$68.18M	$39.45M
YoY Change	-59.48%	-82.51%
Cash & Equivalents	$68.18M	$39.45M
Short-Term Investments	$0.00	$0.00
Other Short-Term Assets	$81.51M	$65.67M
YoY Change	69.24%	-10.82%
Inventory	$152.5M	$137.3M
Prepaid Expenses
Receivables	$105.0M	$123.5M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$418.0M	$378.2M
YoY Change	-2.1%	-23.92%
LONG-TERM ASSETS
Property, Plant & Equipment	$519.4M	$616.5M
YoY Change	4.34%	39.15%
Goodwill
YoY Change
Intangibles	$2.854M	$2.985M
YoY Change	-14.63%	-19.13%
Long-Term Investments
YoY Change
Other Assets	$11.49M	$9.954M
YoY Change	-68.59%	-65.81%
Total Long-Term Assets	$566.5M	$662.5M
YoY Change	-0.73%	30.68%
TOTAL ASSETS
Total Short-Term Assets	$418.0M	$378.2M
Total Long-Term Assets	$566.5M	$662.5M
Total Assets	$984.6M	$1.041B
YoY Change	-1.31%	3.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$79.89M	$83.07M
YoY Change	47.08%	101.42%
Accrued Expenses	$28.40M	$27.18M
YoY Change	157.43%	164.46%
Deferred Revenue	$40.81M	$41.28M
YoY Change	-23.08%	-22.21%
Short-Term Debt	$60.03M	$41.03M
YoY Change	231.37%	87.87%
Long-Term Debt Due	$60.03M
YoY Change
Total Short-Term Liabilities	$372.5M	$366.6M
YoY Change	27.28%	31.99%
LONG-TERM LIABILITIES
Long-Term Debt	$90.67M	$86.19M
YoY Change	21.03%	18.05%
Other Long-Term Liabilities	$26.68M	$25.24M
YoY Change	-16.75%	-19.41%
Total Long-Term Liabilities	$26.68M	$25.24M
YoY Change	-16.75%	-19.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$372.5M	$366.6M
Total Long-Term Liabilities	$26.68M	$25.24M
Total Liabilities	$506.5M	$494.5M
YoY Change	21.17%	24.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.001B	-$922.3M
YoY Change	18.18%	12.38%
Common Stock	$32.00K	$32.00K
YoY Change	3.23%	3.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$478.1M	$546.1M
YoY Change
Total Liabilities & Shareholders Equity	$984.6M	$1.041B
YoY Change	-1.31%	3.65%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$78.44M	-$24.83M
YoY Change	200.67%	-16.08%
Depreciation, Depletion And Amortization	$7.708M	$7.591M
YoY Change	51.17%	48.93%
Cash From Operating Activities	$111.0K	$2.031M
YoY Change	-100.37%	-118.19%
INVESTING ACTIVITIES
Capital Expenditures	$2.945M	$10.24M
YoY Change	-94.9%	-71.49%
Acquisitions
YoY Change
Other Investing Activities	$28.00K	$5.716M
YoY Change	-78.79%	5792.78%
Cash From Investing Activities	-$2.917M	-$4.525M
YoY Change	-94.93%	-87.37%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.23M	$6.260M
YoY Change	2345.32%	42.79%
NET CHANGE
Cash From Operating Activities	111.0K	$2.031M
Cash From Investing Activities	-2.917M	-$4.525M
Cash From Financing Activities	22.23M	$6.260M
Net Change In Cash	19.42M	-$1.485M
YoY Change	-122.45%	-96.48%
FREE CASH FLOW
Cash From Operating Activities	$111.0K	$2.031M
Capital Expenditures	$2.945M	$10.24M
Free Cash Flow	-$2.834M	-$8.210M
YoY Change	-96.76%	-82.56%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	616508000	usd
CY2023Q4	mvst	Land Use Rights Net LandUseRightsNet	11984000	usd
CY2024Q1	mvst	Land Use Rights Net LandUseRightsNet	11712000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	3136000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2985000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	19507000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18777000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9661000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9954000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	35392000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	41034000	usd
CY2023Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	655000	usd
CY2024Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	653000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	403410000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	366620000	usd
CY2023Q4	mvst	Long Term Bonds Payables LongTermBondsPayables	43157000	usd
CY2024Q1	mvst	Long Term Bonds Payables LongTermBondsPayables	43157000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	43761000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	43031000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	67000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	25000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	199000	usd
CY2024Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	197000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	17087000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	16234000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24861000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	494502000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	316694442	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	317196095	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	315006942	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	315508595	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	32000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1481241000	usd
CY2023Q4	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6032000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-897501000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-922326000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25614000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30731000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29571000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	43087000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	41276000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25238000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	532542000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1493139000	usd
CY2024Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	6032000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	425606000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	378152000	usd
CY2023Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6171000	usd
CY2024Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2560000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	620667000	usd
CY2023Q4	us-gaap	Assets Assets	1096732000	usd
CY2024Q1	us-gaap	Assets Assets	1040648000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	112618000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	83071000	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	63374000	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	63355000	usd
CY2023Q4	mvst	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	148284000	usd
CY2024Q1	mvst	Accrued Expenses And Other Liabilities Current AccruedExpensesAndOtherLiabilitiesCurrent	137231000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	564190000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	546146000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1096732000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1040648000	usd
CY2023Q1	us-gaap	Revenues Revenues	46973000	usd
CY2024Q1	us-gaap	Revenues Revenues	81351000	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	42115000	usd
CY2024Q1	us-gaap	Cost Of Revenue CostOfRevenue	64126000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4858000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	17225000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	20385000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23794000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10861000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11492000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4988000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5591000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	36234000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	40877000	usd
CY2023Q1	mvst	Subsidy Income SubsidyIncome	77000	usd
CY2024Q1	mvst	Subsidy Income SubsidyIncome	534000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-31299000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-23118000	usd
CY2023Q1	mvst	Interest Income InterestIncome	1381000	usd
CY2024Q1	mvst	Interest Income InterestIncome	119000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	459000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	1732000	usd
CY2023Q1	mvst	Gain On Change In Fair Value Of Warrant Liability GainOnChangeInFairValueOfWarrantLiability	17000	usd
CY2024Q1	mvst	Gain On Change In Fair Value Of Warrant Liability GainOnChangeInFairValueOfWarrantLiability	42000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	789000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-136000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-29571000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-24825000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29571000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-24825000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	10000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-29581000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-24825000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307714841	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307714841	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	315367121	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	315367121	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29571000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-24825000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	2188000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-5117000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-27383000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-29942000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-22000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-27361000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-29942000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	612977000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	2174000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18061000	usd
CY2023Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	2188000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	605829000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29571000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-24825000	usd
CY2023Q1	mvst	Gain Loss On Disposal Of Property Plant And Equipment GainLossOnDisposalOfPropertyPlantAndEquipment	824000	usd
CY2024Q1	mvst	Gain Loss On Disposal Of Property Plant And Equipment GainLossOnDisposalOfPropertyPlantAndEquipment	-34000	usd
CY2023Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	4892000	usd
CY2024Q1	us-gaap	Depreciation Nonproduction DepreciationNonproduction	7470000	usd
CY2023Q1	mvst	Amortization Of Land Use Right And Intangible Assets AmortizationOfLandUseRightAndIntangibleAssets	205000	usd
CY2024Q1	mvst	Amortization Of Land Use Right And Intangible Assets AmortizationOfLandUseRightAndIntangibleAssets	194000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	658000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	664000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	17929000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11865000	usd
CY2023Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-17000	usd
CY2024Q1	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-42000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-1094000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	578000	usd
CY2023Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	2530000	usd
CY2024Q1	us-gaap	Product Warranty Expense ProductWarrantyExpense	3269000	usd
CY2023Q1	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	21340000	usd
CY2024Q1	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-10577000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-32293000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-12011000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7039000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-16341000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	857000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4305000	usd
CY2023Q1	mvst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	2493000	usd
CY2024Q1	mvst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	323000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-288000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	275000	usd
CY2023Q1	mvst	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	-936000	usd
CY2024Q1	mvst	Increase Decrease In Notes Payable IncreaseDecreaseInNotesPayable	1042000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-3956000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-27843000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1179000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1694000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-3434000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-10623000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	1239000	usd
CY2024Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-500000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-108000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-126000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11166000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2031000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35922000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	10241000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	243000	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	0	usd
CY2023Q1	mvst	Proceeds On Disposal Of Property Plant And Equipment ProceedsOnDisposalOfPropertyPlantAndEquipment	340000	usd
CY2024Q1	mvst	Proceeds On Disposal Of Property Plant And Equipment ProceedsOnDisposalOfPropertyPlantAndEquipment	152000	usd
CY2023Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2024Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	5564000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35825000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4525000	usd
CY2023Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	4384000	usd
CY2024Q1	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	18780000	usd
CY2023Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	0	usd
CY2024Q1	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	12520000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4384000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6260000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	470000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-5251000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-42137000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1485000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	302617000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	88189000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	260480000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	86704000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	200305000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39451000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	60175000	usd
CY2024Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	47253000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	260480000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	86704000	usd
CY2023Q1	mvst	Payable For Purchase Of Property Plant And Equipment PayableForPurchaseOfPropertyPlantAndEquipment	58121000	usd
CY2024Q1	mvst	Payable For Purchase Of Property Plant And Equipment PayableForPurchaseOfPropertyPlantAndEquipment	92817000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microvast, Inc. was incorporated under the laws of the State of Texas in the United States of America on October 12, 2006 and re-domiciled to the State of Delaware on December 31, 2015. On July 23, 2021 (the “Closing Date”), Microvast, Inc. and Tuscan Holdings Corp.(“Tuscan”) consummated the previously announced merger (the “Merger” or the "Business Combination"), pursuant to the Agreement and Plan of Merger (the “Merger Agreement”) dated February 1, 2021, between Tuscan, Microvast, Inc. and TSCN Merger Sub Inc., a Delaware corporation (“Merger Sub”).</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the Merger Agreement, the Merger Sub merged with and into Microvast, Inc., with Microvast, Inc. surviving the Merger. As a result of the Merger, Tuscan was renamed “Microvast Holdings, Inc.” (the “Company”). The Merger was accounted for as a reverse recapitalization as Microvast, Inc. was determined to be the accounting acquirer under Financial Accounting Standards Board’s Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”). </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company and its subsidiaries (collectively, the “Group”) are primarily engaged in developing, manufacturing, and selling electronic power products for electric vehicles and energy storage across the globe.</span></div>
CY2023Q1	us-gaap	Revenues Revenues	46973000	usd
CY2024Q1	us-gaap	Revenues Revenues	81351000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	4858000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	17225000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-29571000	usd
CY2023Q4	mvst	Accrued Payroll And Welfare AccruedPayrollAndWelfare	8089000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-24825000	usd
CY2024Q1	mvst	Working Capital WorkingCapital	11532000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	546146000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-922326000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39451000	usd
CY2024Q1	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	84065000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	41034000	usd
CY2024Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	325586000	usd
CY2024Q1	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	5456000	usd
CY2024Q1	mvst	Liens Amount LiensAmount	31713000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	46973000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	81351000	usd
CY2023Q1	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	1788000	usd
CY2024Q1	mvst	Revenue Related To Contracts Balance RevenueRelatedToContractsBalance	3922000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	18777000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18760000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2526000	usd
CY2023Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	143288000	usd
CY2024Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	128608000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	4571000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	5065000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	138717000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	123543000	usd
CY2022Q4	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	4407000	usd
CY2023Q4	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	4571000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	578000	usd
CY2023Q1	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	66000	usd
CY2024Q1	mvst	Accounts Receivable Write Off AccountsReceivableWriteOff	0	usd
CY2023Q1	mvst	Accounts Receivable Exchange Difference AccountsReceivableExchangeDifference	23000	usd
CY2024Q1	mvst	Accounts Receivable Exchange Difference AccountsReceivableExchangeDifference	-84000	usd
CY2023Q1	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	3270000	usd
CY2024Q1	mvst	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	5065000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	86379000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	82681000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	35867000	usd
CY2024Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	37043000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	27503000	usd
CY2024Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17606000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	149749000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	137330000	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2024Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5472000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5431000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2336000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2446000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3136000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2985000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	129000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	121000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	362000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	480000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	478000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	472000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	382000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	376000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	435000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2985000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13738000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13401000	usd
CY2023Q4	mvst	Payables For Purchase Of Property Plant And Equipment PayablesForPurchaseOfPropertyPlantAndEquipment	96350000	usd
CY2024Q1	mvst	Payables For Purchase Of Property Plant And Equipment PayablesForPurchaseOfPropertyPlantAndEquipment	92817000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	14312000	usd
CY2024Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	16666000	usd
CY2024Q1	mvst	Accrued Payroll And Welfare AccruedPayrollAndWelfare	5966000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	6224000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current And Noncurrent AccruedLiabilitiesCurrentAndNoncurrent	4872000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	41000	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	411000	usd
CY2023Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	7117000	usd
CY2024Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	572000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2413000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2526000	usd
CY2023Q4	mvst	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	148284000	usd
CY2024Q1	mvst	Accrued Expense And Other Liabilities Current AccruedExpenseAndOtherLiabilitiesCurrent	137231000	usd
CY2022Q4	mvst	Movement Of Product Warranty Opening Balance MovementOfProductWarrantyOpeningBalance	42060000	usd
CY2023Q4	mvst	Movement Of Product Warranty Opening Balance MovementOfProductWarrantyOpeningBalance	35217000	usd
CY2023Q1	mvst	Warranty Expense Provided During The Period WarrantyExpenseProvidedDuringThePeriod	2530000	usd
CY2024Q1	mvst	Warranty Expense Provided During The Period WarrantyExpenseProvidedDuringThePeriod	3269000	usd
CY2023Q1	mvst	Utilization Of The Product Warranty During The Period UtilizationOfTheProductWarrantyDuringThePeriod	5172000	usd
CY2024Q1	mvst	Utilization Of The Product Warranty During The Period UtilizationOfTheProductWarrantyDuringThePeriod	2448000	usd
CY2023Q1	mvst	Warranty Expense Exchange Difference During The Period WarrantyExpenseExchangeDifferenceDuringThePeriod	192000	usd
CY2024Q1	mvst	Warranty Expense Exchange Difference During The Period WarrantyExpenseExchangeDifferenceDuringThePeriod	-590000	usd
CY2023Q1	mvst	Movement Of Product Warranty Ending Balance MovementOfProductWarrantyEndingBalance	39610000	usd
CY2024Q1	mvst	Movement Of Product Warranty Ending Balance MovementOfProductWarrantyEndingBalance	35448000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13738000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	13401000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	21479000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	22047000	usd
CY2023Q4	mvst	Product Warranty Total ProductWarrantyTotal	35217000	usd
CY2024Q1	mvst	Product Warranty Total ProductWarrantyTotal	35448000	usd
CY2023Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	524000	usd
CY2024Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	0	usd
CY2022Q4	mvst	Bank Borrowings Beginning Balance BankBorrowingsBeginningBalance	46395000	usd
CY2023Q4	mvst	Bank Borrowings Beginning Balance BankBorrowingsBeginningBalance	79153000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	4384000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	18780000	usd
CY2023Q1	mvst	Repayments Of Principal RepaymentsOfPrincipal	0	usd
CY2024Q1	mvst	Repayments Of Principal RepaymentsOfPrincipal	12520000	usd
CY2023Q1	mvst	Exchange Difference ExchangeDifference	185000	usd
CY2024Q1	mvst	Exchange Difference ExchangeDifference	-1348000	usd
CY2023Q1	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	50964000	usd
CY2024Q1	mvst	Bank Borrowings Ending Balance BankBorrowingsEndingBalance	84065000	usd
CY2023Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	35392000	usd
CY2024Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	41034000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	43761000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	43031000	usd
CY2023Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	79153000	usd
CY2024Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	84065000	usd
CY2023Q4	mvst	Pledged Buildings PledgedBuildings	124565000	usd
CY2024Q1	mvst	Pledged Buildings PledgedBuildings	120960000	usd
CY2023Q4	mvst	Pledged Machinery And Equipment PledgedMachineryAndEquipment	0	usd
CY2024Q1	mvst	Pledged Machinery And Equipment PledgedMachineryAndEquipment	7768000	usd
CY2023Q4	mvst	Pledged Land Use Rights PledgedLandUseRights	11984000	usd
CY2024Q1	mvst	Pledged Land Use Rights PledgedLandUseRights	11712000	usd
CY2023Q4	mvst	Pledged Construction In Progress PledgedConstructionInProgress	0	usd
CY2024Q1	mvst	Pledged Construction In Progress PledgedConstructionInProgress	599000	usd
CY2023Q4	mvst	Pledged Total Asset PledgedTotalAsset	136549000	usd
CY2024Q1	mvst	Pledged Total Asset PledgedTotalAsset	141039000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	21479000	usd
CY2024Q1	us-gaap	Product Warranty Accrual Noncurrent ProductWarrantyAccrualNoncurrent	22047000	usd
CY2023Q4	mvst	Deferred Subsidy Income Noncurrent DeferredSubsidyIncomeNoncurrent	3382000	usd
CY2024Q1	mvst	Deferred Subsidy Income Noncurrent DeferredSubsidyIncomeNoncurrent	3191000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24861000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	25238000	usd
CY2023Q4	mvst	Long Term Bonds Payable LongTermBondsPayable	43157000	usd
CY2024Q1	mvst	Long Term Bonds Payable LongTermBondsPayable	43157000	usd
CY2018Q4	mvst	Bond Loan BondLoan	87776000	usd
CY2018Q4	mvst	Bond Loan BondLoan	600000000	cny
CY2018Q4	mvst	Equity Holding Pledged Percentage EquityHoldingPledgedPercentage	0.1239
CY2024Q1	mvst	Debt Instrument Convertible Amount Subsidiary Value Threshold DebtInstrumentConvertibleAmountSubsidiaryValueThreshold	950000000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14629000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000000	cny
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	14630000	usd
CY2022Q4	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	100000000	cny
CY2024Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12
CY2024Q1	mvst	Debt Instrument Of Subscribed Amount DebtInstrumentOfSubscribedAmount	43157000	usd
CY2024Q1	mvst	Debt Instrument Of Subscribed Amount DebtInstrumentOfSubscribedAmount	295000000	cny
CY2021Q3	us-gaap	Stock Issued During Period Shares Purchase Of Assets StockIssuedDuringPeriodSharesPurchaseOfAssets	27600000	shares
CY2021Q3	mvst	Class Of Warrant Or Right Exercisable Period ClassOfWarrantOrRightExercisablePeriod	P30D
CY2021Q3	mvst	Warrant Term WarrantTerm	P5Y
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	44541000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	43648000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	88189000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	67000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	67000	usd
CY2024Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	39451000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	47253000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	86704000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	25000	usd
CY2024Q1	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	25000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	126000	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	67000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	17000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	42000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	109000	usd
CY2024Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	25000	usd
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	860000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	159000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P10Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.052
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	869000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	466000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	2661000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2810000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2539000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	2396000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1820000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1628000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	9901000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	23755000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	4995000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	18760000	usd
CY2021Q3	us-gaap	Standby Bond Purchase Commitment Expiration Period StandbyBondPurchaseCommitmentExpirationPeriod	P10Y
CY2021Q3	mvst	Exchange Ratio ExchangeRatio	160.3
CY2021Q3	mvst	Common Stock Reserved For Esop Plan CommonStockReservedForESOPPlan	0.05
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36091071	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.08
CY2022Q4	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y9M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	240000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.25
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.67
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	128239	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	6.28
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	4.86
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	36202832	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.05
CY2023Q1	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.77
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	36202832	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.05
CY2023Q1	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable	4.77
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P6Y7M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	11779651	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.19
CY2023Q1	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	5.00
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	32876682	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.01
CY2023Q4	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.73
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y8M12D
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	884470	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	4.11
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	2.68
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	31992212	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.06
CY2024Q1	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueOutstanding	4.78
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y6M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	31992212	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	6.06
CY2024Q1	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Grant Date Fair Value Expected To Vest And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValueExpectedToVestAndExercisable	4.78
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P5Y6M
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	20875499	shares
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	6.13
CY2024Q1	mvst	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageGrantDateFairValue	4.88
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y6M
CY2024Q1	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	17104000	usd
CY2024Q1	us-gaap	Net Amount At Risk By Product And Guarantee Weighted Average Period Remaining1 NetAmountAtRiskByProductAndGuaranteeWeightedAveragePeriodRemaining1	P0Y4M24D
CY2024Q1	mvst	Aggregate Intrinsic Value Of The Share Options AggregateIntrinsicValueOfTheShareOptions	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1557000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Incremental Compensation Cost ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost	4196000	usd
CY2023Q1	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	1504000	usd
CY2024Q1	mvst	Share Based Compensation Cost Of Sales ShareBasedCompensationCostOfSales	1138000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	12168000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8167000	usd
CY2023Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	3014000	usd
CY2024Q1	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	1777000	usd
CY2023Q1	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	1243000	usd
CY2024Q1	us-gaap	Other Selling And Marketing Expense OtherSellingAndMarketingExpense	783000	usd
CY2023Q1	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	140000	usd
CY2024Q1	mvst	Share Based Compensation Construction In Process ShareBasedCompensationConstructionInProcess	31000	usd
CY2023Q1	mvst	Stock Based Compensation Total StockBasedCompensationTotal	18069000	usd
CY2024Q1	mvst	Stock Based Compensation Total StockBasedCompensationTotal	11896000	usd
CY2023Q1	mvst	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-29581000	usd
CY2024Q1	mvst	Net Income Loss Available To Common Stockholders NetIncomeLossAvailableToCommonStockholders	-24825000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	307714841	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	307714841	shares
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	315367121	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	315367121	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.10
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
CY2024Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1251000	usd
CY2024Q1	mvst	Liens Amount LiensAmount	31713000	usd
CY2024Q1	us-gaap	Debt Default Longterm Debt Amount DebtDefaultLongtermDebtAmount	5456000	usd

Files In Submission

Name	View Source	Status
0001760689-24-000016-index-headers.html	Edgar Link	pending
0001760689-24-000016-index.html	Edgar Link	pending
0001760689-24-000016.txt	Edgar Link	pending
0001760689-24-000016-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mvst-20240331.htm	Edgar Link	pending
mvst-20240331.xsd	Edgar Link	pending
mvst20240331-ex311.htm	Edgar Link	pending
mvst20240331-ex312.htm	Edgar Link	pending
mvst20240331-ex321.htm	Edgar Link	pending
mvst20240331-ex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
mvst-20240331_lab.xml	Edgar Link	unprocessable
mvst-20240331_pre.xml	Edgar Link	unprocessable
mvst-20240331_htm.xml	Edgar Link	completed
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mvst-20240331_cal.xml	Edgar Link	unprocessable
mvst-20240331_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MVST
Microvast Holdings, Inc. Stock $mvst

2024 Q2 Form 10-Q Financial Statement

#000176068924000016 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVST Microvast Holdings, Inc. Stock $mvst

2024 Q2 Form 10-Q Financial Statement

#000176068924000016 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MVST
Microvast Holdings, Inc. Stock $mvst